drugset / Trial / NCT05181748
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Phase 2/3
Recruiting
100 enrolled
Genesis Athens Clinic
National and Kapodistrian University of Athens · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.
Timeline
- Start
- 2019-01-23
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |